Stockreport

iTeos to Participate in Upcoming Investor Conferences

iTeos Therapeutics, Inc.  (ITOS) 
PDF WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 28, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical compan [Read more]